Abstract
Prostatic neuroendocrine (NE) carcinoma is a rare disease with a poor prognosis because of its rapid progression and the androgen-independent characteristic, for which no successful therapy is available presently. We report a case of NE differentiated prostate cancer, which was diagnosed as adenocarcinoma initially and progressed with NE differentiation during the combined androgen blockade therapy.
Publication types
-
Case Reports
-
English Abstract
MeSH terms
-
Adenocarcinoma / drug therapy
-
Adenocarcinoma / pathology*
-
Aged
-
Aged, 80 and over
-
Androgen Antagonists / therapeutic use*
-
Carcinoma, Neuroendocrine / pathology*
-
Cell Transformation, Neoplastic / pathology*
-
Drug Resistance, Neoplasm
-
Humans
-
Magnetic Resonance Imaging
-
Male
-
Neoplasm Staging
-
Prostatic Neoplasms / drug therapy
-
Prostatic Neoplasms / pathology*